(1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one

C34H55NO7Si — CID 135722627

IUPAC(1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one
SMILESCC[C@@H]1OC(=O)[C@H](C)[C@H]2O[C@@H](c3ccccc3)O[C@H]([C@H]2C)[C@](C)(O[Si](CC)(CC)CC)C[C@H](C)C2=NO[C@H]([C@H]2C)[C@]1(C)O
InChIInChI=1S/C34H55NO7Si/c1-11-26-34(10,37)30-22(6)27(35-41-30)21(5)20-33(9,42-43(12-2,13-3)14-4)29-23(7)28(24(8)31(36)38-26)39-32(40-29)25-18-16-15-17-19-25/h15-19,21-24,26,28-30,32,37H,11-14,20H2,1-10H3/t21-,22-,23-,24+,26-,28-,29+,30+,32+,33+,34+/m0/s1
InChIKeyAAHLTHDJODODPL-IZAPZANGSA-N
MW617.90 g/mol
LogP7.03
Rot. Bonds7

About (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one

(1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one (PubChem CID 135722627) has the molecular formula C34H55NO7Si and a molecular weight of 617.90 g/mol. Its IUPAC name is (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one.

Molecular Properties

Compound Name(1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one
PubChem CID135722627
Molecular FormulaC34H55NO7Si
Molecular Weight617.90 g/mol
Exact Mass617.37
IUPAC Name(1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one
SMILESCC[C@@H]1OC(=O)[C@H](C)[C@H]2O[C@@H](c3ccccc3)O[C@H]([C@H]2C)[C@](C)(O[Si](CC)(CC)CC)C[C@H](C)C2=NO[C@H]([C@H]2C)[C@]1(C)O
InChIInChI=1S/C34H55NO7Si/c1-11-26-34(10,37)30-22(6)27(35-41-30)21(5)20-33(9,42-43(12-2,13-3)14-4)29-23(7)28(24(8)31(36)38-26)39-32(40-29)25-18-16-15-17-19-25/h15-19,21-24,26,28-30,32,37H,11-14,20H2,1-10H3/t21-,22-,23-,24+,26-,28-,29+,30+,32+,33+,34+/m0/s1
InChIKeyAAHLTHDJODODPL-IZAPZANGSA-N
XLogP7.03
TPSA95.81 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms43
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500617.90
LogP ≤ 57.03
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one?
The IUPAC name of (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one (CID 135722627) is (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one.
What is the SMILES notation for (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one?
The canonical SMILES for (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one is CC[C@@H]1OC(=O)[C@H](C)[C@H]2O[C@@H](c3ccccc3)O[C@H]([C@H]2C)[C@](C)(O[Si](CC)(CC)CC)C[C@H](C)C2=NO[C@H]([C@H]2C)[C@]1(C)O.
What is the InChIKey of (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one?
The InChIKey is AAHLTHDJODODPL-IZAPZANGSA-N. The full InChI is InChI=1S/C34H55NO7Si/c1-11-26-34(10,37)30-22(6)27(35-41-30)21(5)20-33(9,42-43(12-2,13-3)14-4)29-23(7)28(24(8)31(36)38-26)39-32(40-29)25-18-16-15-17-19-25/h15-19,21-24,26,28-30,32,37H,11-14,20H2,1-10H3/t21-,22-,23-,24+,26-,28-,29+,30+,32+,33+,34+/m0/s1.
What are the key properties of (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one?
(1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one has a molecular weight of 617.90 g/mol, XLogP of 7.03, 7 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2R,4S,8R,9R,10S,13R,14S,16R,18S,19S)-10-ethyl-9-hydroxy-2,4,9,13,18,19-hexamethyl-16-phenyl-2-triethylsilyloxy-7,11,15,17-tetraoxa-6-azatricyclo[12.3.1.15,8]nonadec-5-en-12-one is sourced from PubChem (CID 135722627), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).